Published in Br J Cancer on December 11, 2007
ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation. Cell Stem Cell (2013) 2.32
The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron (2011) 1.67
The inflammatory microenvironment in colorectal neoplasia. PLoS One (2011) 1.62
Analysis of the human pancreatic stellate cell secreted proteome. Pancreas (2011) 1.16
Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis. Cancer Res (2012) 1.02
Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically. Oncol Lett (2012) 1.01
The proteomics of colorectal cancer: identification of a protein signature associated with prognosis. PLoS One (2011) 1.00
Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis. BMC Genomics (2009) 1.00
Annexin A10 is a marker for the serrated pathway of colorectal carcinoma. Virchows Arch (2014) 0.99
Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis. PLoS One (2012) 0.98
Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue. J Mol Diagn (2011) 0.97
Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget (2013) 0.94
Up-regulated Annexin A1 expression in gastrointestinal cancer is associated with cancer invasion and lymph node metastasis. Exp Ther Med (2011) 0.93
Cell surface markers in colorectal cancer prognosis. Int J Mol Sci (2010) 0.90
Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer. PLoS One (2012) 0.90
Up-regulation of hnRNP A1, Ezrin, tubulin β-2C and Annexin A1 in sentinel lymph nodes of colorectal cancer. World J Gastroenterol (2010) 0.89
Quantitative analysis of self-association and mobility of annexin A4 at the plasma membrane. Biophys J (2013) 0.88
Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas. Br J Cancer (2014) 0.86
Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells. PLoS One (2013) 0.85
A Review: Proteomics in Nasopharyngeal Carcinoma. Int J Mol Sci (2015) 0.84
Helicobacter pylori disrupts host cell membranes, initiating a repair response and cell proliferation. Int J Mol Sci (2012) 0.84
Annexin A1 in primary tumors promotes melanoma dissemination. Clin Exp Metastasis (2014) 0.84
A three-protein signature and clinical outcome in esophageal squamous cell carcinoma. Oncotarget (2015) 0.84
Identification of Annexin A4 as a hepatopancreas factor involved in liver cell survival. Dev Biol (2014) 0.83
Revealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arrays. PLoS One (2012) 0.83
Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissue microarray. World J Gastroenterol (2013) 0.83
Analysis and prediction of cancerlectins using evolutionary and domain information. BMC Res Notes (2011) 0.82
Hydrophobic protein in colorectal cancer in relation to tumor stages and grades. World J Gastroenterol (2010) 0.81
Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner. Oncotarget (2014) 0.81
Impact of obesity and leptin on protein expression profiles in mouse colon. Dig Dis Sci (2010) 0.81
Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study. Mol Cell Proteomics (2014) 0.80
Proteomic identification of tumor biomarkers associated with primary gallbladder cancer. World J Gastroenterol (2014) 0.79
A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells. Oncotarget (2016) 0.79
Expression and significance of annexin A2 in patients with gastric adenocarcinoma and the association with E-cadherin. Exp Ther Med (2015) 0.78
Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential? Br J Cancer (2013) 0.78
Prioritization of cancer marker candidates based on the immunohistochemistry staining images deposited in the human protein atlas. PLoS One (2013) 0.78
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling. PLoS One (2015) 0.78
Nuclear accumulation of annexin A2 contributes to chromosomal instability by coilin-mediated centromere damage. Oncogene (2014) 0.76
Identification of O-Linked Glycoproteins Binding to the Lectin Helix pomatia Agglutinin as Markers of Metastatic Colorectal Cancer. PLoS One (2015) 0.76
Proteomic analysis of NME1/NDPK A null mouse liver: evidence for a post-translational regulation of annexin IV and EF-1Bα. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.75
Annexin A13 promotes tumor cell invasion in vitro and is associated with metastasis in human colorectal cancer. Oncotarget (2017) 0.75
Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer. Sci Rep (2016) 0.75
Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer. Cancer Sci (2017) 0.75
Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis. BMC Cancer (2016) 0.75
ANXA11 regulates the tumorigenesis, lymph node metastasis and 5-fluorouracil sensitivity of murine hepatocarcinoma Hca-P cells by targeting c-Jun. Oncotarget (2016) 0.75
Extracellular vesicles released from cells exposed to reactive oxygen species increase annexin A2 expression and survival of target cells exposed to the same conditions. Commun Integr Biol (2016) 0.75
Muscadine Grape Skin Extract Induces an Unfolded Protein Response-Mediated Autophagy in Prostate Cancer Cells: A TMT-Based Quantitative Proteomic Analysis. PLoS One (2016) 0.75
Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer. BMC Cancer (2016) 0.75
Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics. Sci Rep (2017) 0.75
Quantitative proteome analysis of colorectal cancer-related differential proteins. J Cancer Res Clin Oncol (2016) 0.75
Annexins: from structure to function. Physiol Rev (2002) 6.78
Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol (2005) 5.71
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24
Annexins--unique membrane binding proteins with diverse functions. J Cell Sci (2004) 2.74
Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med (1996) 2.42
Annexin 1: the new face of an old molecule. FASEB J (2007) 2.16
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). Lancet (2004) 1.85
Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol (2004) 1.65
Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol (2003) 1.60
Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol (2006) 1.60
Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol (2006) 1.57
Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem (2006) 1.55
Actin microfilament aggregation induced by withaferin A is mediated by annexin II. Nat Chem Biol (2005) 1.55
Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res (2001) 1.55
Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol (2005) 1.53
Annexin 11 is required for midbody formation and completion of the terminal phase of cytokinesis. J Cell Biol (2004) 1.52
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res (2000) 1.50
Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. J Pathol (2006) 1.41
Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim Biophys Acta (2000) 1.38
Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer (2001) 1.34
ANX7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci U S A (2001) 1.26
Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res (2005) 1.25
Annexins and disease. Biochem Biophys Res Commun (2004) 1.25
Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett (2004) 1.25
Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res (2006) 1.21
Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J Pathol (2006) 1.20
Modulation of paclitaxel resistance by annexin IV in human cancer cell lines. Br J Cancer (2000) 1.12
Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer (2004) 1.10
Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin Cancer Res (2004) 1.05
Annexin 2 expression is reduced in human osteosarcoma metastases. J Cell Biochem (2004) 1.03
Three-dimensional structure of annexins. Cell Mol Life Sci (1997) 1.02
The annexinopathies: a new category of diseases. Biochim Biophys Acta (2000) 1.01
Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients. Clin Cancer Res (2004) 0.97
Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J Cell Biochem (2005) 0.97
Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome. Virchows Arch (2004) 0.96
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer (2004) 0.94
Dissecting the cellular functions of annexin XI using recombinant human annexin XI-specific autoantibodies cloned by phage display. J Biol Chem (2003) 0.93
Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology (2005) 0.92
A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells. Proteomics (2006) 0.90
Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: cancer association of annexin A3. Proteomics (2007) 0.89
Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin. J Immunol (2007) 0.89
Angiostatin receptor annexin II in vascular tumors including angiosarcoma. Hum Pathol (2007) 0.88
Expression of annexin AI in conventional renal cell carcinoma (CRCC) correlates with tumour stage, Fuhrman grade, amount of eosinophilic cells and clinical outcome. Histol Histopathol (2007) 0.82
Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer (2000) 2.73
Matrix metalloproteinases in tumour invasion and metastasis. J Pathol (1999) 2.65
Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology (2001) 2.25
The role of annexins in tumour development and progression. J Pathol (2008) 1.75
Tumour markers of prognosis in colorectal cancer. Br J Cancer (1999) 1.68
Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer (2006) 1.65
The spectrum of postmortem ocular findings in victims of shaken baby syndrome. Can J Ophthalmol (2001) 1.62
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases. Eur J Cancer (2002) 1.49
Laser capture microscopy. Mol Pathol (2000) 1.43
Some thoughts on the nature of ectopic parathyroid hormones. Am J Med (1971) 1.39
Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1. J Histochem Cytochem (1999) 1.33
Proteomics: a new approach to the study of disease. J Pathol (2000) 1.32
Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol (2002) 1.27
Comparative genomic hybridization and chromosomal instability in solid tumours. Br J Cancer (1999) 1.24
Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation? J Pharmacol Exp Ther (2001) 1.24
Characterization of mouse urea transporters UT-A1 and UT-A2. Am J Physiol Renal Physiol (2002) 1.24
Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. J Pathol (2006) 1.20
A highly sensitive detection method for immunohistochemistry using biotinylated tyramine. J Pathol (1997) 1.18
Improved Movat pentachrome stain. Stain Technol (1986) 1.11
Liver fatty acid binding protein expression in colorectal neoplasia. Br J Cancer (2004) 1.10
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. Br J Cancer (2001) 1.09
The 'turkey wattle' sign revisited: diagnosing parotid vascular malformations in the adult. Br J Plast Surg (1997) 1.08
Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance. Biochem Pharmacol (2001) 1.08
Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int J Cancer (2000) 1.08
Xenobiotic metabolising enzyme expression in colonic neoplasia. Gut (1993) 1.08
Application of laser capture microdissection and proteomics in colon cancer. Mol Pathol (2001) 1.07
Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett (1995) 1.06
Colorectal cancer genomics: evidence for multiple genotypes which influence survival. Br J Cancer (2001) 1.04
Regulation of the Wilms' tumour suppressor protein transcriptional activation domain. Oncogene (1999) 1.04
Tumour cytochrome P450 and drug activation. Curr Pharm Des (2002) 1.03
Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: implications for MMP inhibition therapy. Oncol Rep (2001) 1.03
c-erbB-2 is not a major factor in the development of colorectal cancer. Br J Cancer (2002) 0.99
Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. Clin Cancer Res (2000) 0.99
Multicenter linkage study of schizophrenia loci on chromosome 22q. Mol Psychiatry (2004) 0.98
Human matrix metalloproteinase-9: activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form. Eur J Biochem (1998) 0.98
Image compression and chest radiograph interpretation: image perception comparison between uncompressed chest radiographs and chest radiographs stored using 10:1 JPEG compression. J Digit Imaging (2000) 0.97
Human papillomavirus 16 infection in adenocarcinoma of the cervix. Br J Cancer (2005) 0.96
An unusual intraoral mass in a child: the organ of Chievitz. J Pediatr Surg (1990) 0.96
COX-2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics. Histopathology (2008) 0.96
Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer (1998) 0.95
Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. Biochem Pharmacol (1998) 0.95
A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol (1991) 0.95
The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions. Curr Cancer Drug Targets (2004) 0.94
Mechanism of perforation occurring in the intussuscipiens during hydrostatic reduction of intussusception. Can J Surg (1982) 0.94
Long-term prostaglandin E1 therapy in congenital heart defects. J Am Coll Cardiol (1984) 0.93
Truncus arteriosus communis associated with mitral valve and left ventricular hypoplasia without ventricular septal defect: unique combination. Pediatr Cardiol (1996) 0.91
CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia. Br J Cancer (2003) 0.89
Hepatic mesenchymal hamartoma in a neonate: a case report and review of the literature. J Pediatr Hematol Oncol (2001) 0.89
Surgical complications of Kawasaki disease. J Pediatr Surg (1981) 0.88
Matrix metalloproteinases: a multifunctional group of molecules. J Pathol (2001) 0.87
Comparison of African-American and white persons with Alzheimer's disease on language measures. Neurology (1997) 0.87
Spot the differences: proteomics in cancer research. Lancet Oncol (2001) 0.87
Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas. Int J Oncol (2000) 0.85
Genomic instability at the BUB1 locus in colorectal cancer, but not in non-small cell lung cancer. Cancer Res (2000) 0.85
Cytochrome P450 CYP1B1 activity in renal cell carcinoma. Br J Cancer (2004) 0.85
Subcutaneous granuloma annulare of the extremities in children. Can J Surg (2000) 0.84
Ectopic renal tissue associated with an undescended testis: a case report. J Urol (1986) 0.84
Hemispheric asymmetries in schizophrenia. Biol Psychiatry (1981) 0.84
Amplification of fluorescent in situ hybridisation signals in formalin fixed paraffin wax embedded sections of colon tumour using biotinylated tyramide. Mol Pathol (1997) 0.84
Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer. Int J Cancer (2001) 0.84
Alveolar soft-part sarcoma of the orbit. Ophthalmic Surg (1995) 0.83
Is wax on the wane? J Pathol (1988) 0.83
A combined elastic, fibrin and collagen stain. Stain Technol (1987) 0.82
Eniluracil treatment completely inactivates dihydropyrimidine dehydrogenase in colorectal tumors. J Clin Oncol (1999) 0.82
Enterococcal endocarditis in early infancy. Can Med Assoc J (1982) 0.82
Localization of microsomal epoxide hydrolase in normal and neoplastic human kidney. J Histochem Cytochem (1995) 0.82
Analysis of uracil DNA glycosylase in human colorectal cancer. Int J Oncol (2001) 0.82
Expression of the Oct-1 transcription factor and characterization of its interactions with the Bob1 coactivator. Biochemistry (2001) 0.82
Segmental agenesis of intestinal muscularis: a case report. J Pediatr Surg (1989) 0.82
Definitive treatment of focal nodular hyperplasia of the liver by ethanol embolization. J Pediatr Surg (1989) 0.82
Extraspinal ependymoma. J Pediatr Surg (1987) 0.81
Primary carcinoid of the prostate in conjunction with multiple endocrine neoplasia IIb in a child. J Urol (1995) 0.81
Fibromatosis in infancy and childhood: the spectrum. J Pediatr Surg (1993) 0.81
Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma. Hum Pathol (1998) 0.80
Glutathione localisation in benign and malignant human breast lesions. Br J Cancer (1987) 0.80
Differential expression of CYP1A1 and CYP1B1 in human breast cancer. Biochem Soc Trans (1996) 0.80
Glutathione localization by a novel o-phthalaldehyde histofluorescence method. Histochem J (1986) 0.80
Differential expression of CYP1A1, CYP1A2, CYP1B1 in human kidney tumours. Cancer Lett (1999) 0.80
Oxalate transport in renal tubular cells from normal and stone-forming animals. Am J Kidney Dis (1991) 0.80
Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer. Int J Cancer (2014) 0.79
Selection of markers to predict tumour response or survival: description of a novel approach. Eur J Cancer (1999) 0.79
Selective in vivo transfection of murine biliary epithelia using polycation-enhanced adenovirus. Gene Ther (2000) 0.78
Varidase: the science behind the medicament. J Wound Care (2000) 0.78
Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential? Br J Cancer (2013) 0.78
Fluorescence-microscopic measurement of intracellular cytochrome P-450 enzyme activity (ethoxyresorufin O-de-ethylation) in unfixed liver section. Biochem J (1983) 0.78
Fatal adenovirus type 35 infection in newborns. Pediatr Infect Dis J (1991) 0.78
Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas. Br J Cancer (2015) 0.78
Evolutionary conserved mechanism of transcriptional repression by even-skipped. Nucleic Acids Res (1999) 0.78
Endothelium and the regulation of coagulation. Pathol Immunopathol Res (1986) 0.78
p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change. Gynecol Oncol (1997) 0.78
Parosteal fasciitis in children. Am J Orthop (Belle Mead NJ) (1995) 0.78
Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes. Drug Metab Dispos (1995) 0.77
Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices. Drug Metab Dispos (1996) 0.77
Potassium depletion enhances renal compensatory hypertrophy in the nephrectomized rat. Miner Electrolyte Metab (1987) 0.77
Cytochrome P450 expression in tumours. J Pathol (1995) 0.76
Pyrrolopyrimidine Nucleosides. I. The Synthesis of 4-Substituted 7-(- D -Ribofuranosyl)pyrrolo[2,3-d]pyrimidines from Tubercidin. J Med Chem (1967) 0.76